Metformin Exhibits Anti‐Inflammatory Effects by Regulating microRNA‐451/CXCL16 and B Cell Leukemia/Lymphoma 2 in Patients With Osteoarthritis
Objective Osteoarthritis (OA) is the most common cause of chronic disability in joints among older individuals. The primary goal of OA treatment is pain relief to improve the quality of life. Inflammation and aging are involved in the pathogenesis of pain in OA. In this study, we evaluated the abili...
Saved in:
Main Authors: | Nahid Alimoradi, Amin Ramezani, Mohammad Tahami, Negar Firouzabadi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | ACR Open Rheumatology |
Online Access: | https://doi.org/10.1002/acr2.11755 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring microRNA pathways and metformin’s anti‐inflammatory potential in osteoarthritis
by: Quang D. La, et al.
Published: (2025-01-01) -
MicroRNA-451 as an Early Predictor of Chronic Kidney Disease in Diabetic Nephropathy
by: Mostafa Abdelsalam, et al.
Published: (2020-01-01) -
MicroRNA-451a is a candidate biomarker and therapeutic target for major depressive disorder
by: Yan Chen, et al.
Published: (2024-02-01) -
T-Cell Lymphoblastic Leukemia/Lymphoma: Relapse 16 Years after First Remission
by: Lauren Elreda, et al.
Published: (2014-01-01) -
B Cell Responses to CpG Correlate with CXCL16 Expression Levels in Common Variable Immunodeficiency
by: Vassilios Lougaris, et al.
Published: (2012-01-01)